Token Cat (TC) Competitors

Token Cat (NASDAQ:TC) and bioAffinity Technologies (NASDAQ:BIAF) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

Which has better earnings and valuation, TC or BIAF?

bioAffinity Technologies has higher revenue and earnings than Token Cat.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Token Cat	$6.74M	0.27	-$25.76M	N/A	N/A
bioAffinity Technologies	$9.36M	0.71	-$9.04M	-$0.72	-0.32

Do institutionals and insiders hold more shares of TC or BIAF?

8.9% of Token Cat shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 0.5% of Token Cat shares are owned by company insiders. Comparatively, 16.9% of bioAffinity Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Is TC or BIAF more profitable?

Token Cat has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -110.53%. Token Cat's return on equity of 0.00% beat bioAffinity Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Token Cat	N/A	N/A	N/A
bioAffinity Technologies	-110.53%	-367.64%	-154.15%

Does the media prefer TC or BIAF?

In the previous week, bioAffinity Technologies had 6 more articles in the media than Token Cat. MarketBeat recorded 7 mentions for bioAffinity Technologies and 1 mentions for Token Cat. Token Cat's average media sentiment score of 1.87 beat bioAffinity Technologies' score of -0.07 indicating that Token Cat is being referred to more favorably in the media.

Company	Overall Sentiment
Token Cat	Very Positive
bioAffinity Technologies	Neutral

Do analysts recommend TC or BIAF?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Token Cat	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
bioAffinity Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more volatility & risk, TC or BIAF?

Token Cat has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of 2.53, indicating that its stock price is 153% more volatile than the S&P 500.

Summary

bioAffinity Technologies beats Token Cat on 7 of the 12 factors compared between the two stocks.